Active Pharmaceutical Ingredients (APIs)

Nanoforming

In 2019, the pharmaceutical industry invested $182 billion in drug development, but only 48 drugs were approved for use.

Flow Chemistry: A Mature Technology still on the Rise

The change in many chemical companies’ product portfolio away from commodities to customer-specific specialties is one of the current challenges facing the process industry.

Continuous Pharmaceutical Manufacturing

Economic Impact and Challenges of Continuous Pharma Processes

AGC Expands Spanish Facilities

FDA Says Pandemic Hasn’t Hit China’s Drug Exports

Biomade Peptides

The Pharma CDMO Challenge

Olon Buys Indian API Plant

With this acquisition, Olon said it has successfully finalized its three-year development plan and will now move to its next target, which is to play an important role in manufacturing biologics APIs.

A Holistic System Approach

Unique Opportunity for Innovation and Improvement

A Visible Reference of Production-scale Micro Reaction Technology

A Technology on the Upswing

Benefits across Different Industries and Applications

Unsurpassed Heat and Mass Transfer Properties

Further Development Will Increase Confidence

A Boost to Efficiency, Adaptability and Responsiveness

Increased Process Performance and Safety

A Technology Whose Use is Indispensable

Flow Chemistry: Key Technology for Sustainable Processes

Francesca Scarpitta Joins Cerbios as Director of HPAI Manufacturing Units

Cerbios has appointed Francesca Scarpitta as director of the company’s high potency active ingredients (HPAIs) production units.

DCAT Week 2019

Mallinckrodt to Split Into two Parts

MENA Pharmaceutical Market

Opportunities for Western CDMOs in China

Industry 4.0 Will Be a Game Changer for the Chemical Business

Lonza and Clovis Open New Monoplant for Ovarian Cancer Drug

Sanofi Completes Divestiture of European Generics Business, Renames Active Ingredient Solutions Business

M&A in Pharma and CRO/CMO Industry

Opposites Attract

If You Want to Go Far, Go Together

Supply Security of Non-cGMP Materials

A Wide Spectrum of Contract Services

Winning Strategies in the Pharmaceutical CDMO Industry

Cambrex to Acquire Halo Pharma